Biotech sector (IBB) is poised to resume an uptrend following a recent recovery.
Bullish
“These Stocks Fell Out of Favor. Now They’re Turning Higher”
StockCharts TVPublished Sep 25 · 1 passage
Jump to any passage
1 passage
Attention should also be paid to biotechnology companies ( IBB), as shares in this group rose by 2.6% . Note the dynamic we saw in mid- August, and much of this rise is due to Moderna's progress in DNA and other areas.
We have seen a remarkable recovery in the group as a whole after its decline, and we are now on the verge of restoring this upward trend. This is another area where we will take a look at some stocks that have declined in popularity and then reappeared.
What this channel has said about $IBB
StockCharts TV has 2 calls on this stock; only the adjacent ones are shown.
2026-09-25BullishThis one
Attention should also be paid to biotechnology companies ( IBB), as shares in this group rose by 2.6% . Note the dynamic we saw in mid- August, and much of this rise is due to Moderna's progress in DNA and other areas. We have seen a remarkable recovery in the group as a whole after its decline, and we are now on the verge of restoring this upward trend. This is another area where we will take a look at some stocks that have declined in popularity and then reappeared.
2026-09-18Bullish
Moving on to key areas of the market, I would like to share my thoughts on healthcare, and one of the main beneficiaries of that movement is the IBB fund. This is a biotechnology exchange-traded fund (ETF), and you can see it is in a position to trade again above its 21-week moving average . We have a positive Relative Strength Index and a positive MACD indicator, and we will delve deeper into this area, but all the areas I mentioned, especially software, semiconductors and now biotechnology. The reason these fields are at the forefront is that, again, semiconductors don't usually do well in a high-interest-rate environment, and the same is true for biotechnology. There is usually a sense of risk aversion, but the main driver for these three areas is innovation in artificial intelligence and new products, and we will address this as we talk.
Quote at 11:50 ›